Phase 1/ Phase 2 Study of the Therapeutic Effect of Ex-vivo Expanded Umbilical Cord Blood Regulatory T Cells With Liraglutide on Autoimmune Diabetes
Latest Information Update: 16 Mar 2023
At a glance
- Drugs Liraglutide (Primary) ; T-lymphocyte cell therapy (Primary) ; Insulin
- Indications Autoimmune disorders; Type 1 diabetes mellitus
- Focus Adverse reactions
- 13 Mar 2023 Planned End Date changed from 1 Dec 2021 to 1 Jun 2025.
- 13 Mar 2023 Planned primary completion date changed from 1 Dec 2021 to 1 Jun 2025.
- 24 Mar 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.